<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4A4FD168-BA47-429C-A08E-6512EC723D43"><gtr:id>4A4FD168-BA47-429C-A08E-6512EC723D43</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology (ICGEB)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46814344-D2A0-4C3A-920A-598FC35388D4"><gtr:id>46814344-D2A0-4C3A-920A-598FC35388D4</gtr:id><gtr:name>University of W?rzburg</gtr:name><gtr:address><gtr:line1>Pleicherwall 2</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5FEE5E83-79D6-4AD2-970E-F076F1AC08A7"><gtr:id>5FEE5E83-79D6-4AD2-970E-F076F1AC08A7</gtr:id><gtr:name>Biodim Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6"><gtr:id>0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6</gtr:id><gtr:name>Hebrew University of Jerusalem</gtr:name><gtr:address><gtr:line1>Mt Scopus</gtr:line1><gtr:line4>Jerusalem</gtr:line4><gtr:line5>91905</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Immunology and Molecular Pathology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A4FD168-BA47-429C-A08E-6512EC723D43"><gtr:id>4A4FD168-BA47-429C-A08E-6512EC723D43</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology (ICGEB)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46814344-D2A0-4C3A-920A-598FC35388D4"><gtr:id>46814344-D2A0-4C3A-920A-598FC35388D4</gtr:id><gtr:name>University of W?rzburg</gtr:name><gtr:address><gtr:line1>Pleicherwall 2</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5FEE5E83-79D6-4AD2-970E-F076F1AC08A7"><gtr:id>5FEE5E83-79D6-4AD2-970E-F076F1AC08A7</gtr:id><gtr:name>Biodim Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6"><gtr:id>0FA0D9A7-79AE-46F8-85E8-D5DB38EE49E6</gtr:id><gtr:name>Hebrew University of Jerusalem</gtr:name><gtr:address><gtr:line1>Mt Scopus</gtr:line1><gtr:line4>Jerusalem</gtr:line4><gtr:line5>91905</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5908AE28-52DA-49ED-A8B3-B78D85922CBE"><gtr:id>5908AE28-52DA-49ED-A8B3-B78D85922CBE</gtr:id><gtr:firstName>Gregory</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Towers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B654ECEC-1671-4888-9A24-6A3246332A48"><gtr:id>B654ECEC-1671-4888-9A24-6A3246332A48</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>Garson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/56CB866B-A1A5-4104-8DB7-5CD2846A339B"><gtr:id>56CB866B-A1A5-4104-8DB7-5CD2846A339B</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Griffiths</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BA08691A-0277-45FB-A759-056325F7766E"><gtr:id>BA08691A-0277-45FB-A759-056325F7766E</gtr:id><gtr:firstName>Arne</gtr:firstName><gtr:otherNames>Nalpon</gtr:otherNames><gtr:surname>Akbar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/74389446-0D26-451F-BC60-01028C798AAD"><gtr:id>74389446-0D26-451F-BC60-01028C798AAD</gtr:id><gtr:firstName>Mala</gtr:firstName><gtr:otherNames>Kunti</gtr:otherNames><gtr:surname>Maini</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D5568E1D-EFE4-448E-821B-3B135E754B5D"><gtr:id>D5568E1D-EFE4-448E-821B-3B135E754B5D</gtr:id><gtr:firstName>Yasuhiro</gtr:firstName><gtr:surname>Takeuchi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F3AC79FF-5DA2-409B-9C45-6E9781A7AFF3"><gtr:id>F3AC79FF-5DA2-409B-9C45-6E9781A7AFF3</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:otherNames>Amanda</gtr:otherNames><gtr:surname>Skok</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EBA4ABCD-0394-4234-8808-94480506F83D"><gtr:id>EBA4ABCD-0394-4234-8808-94480506F83D</gtr:id><gtr:firstName>Mary</gtr:firstName><gtr:surname>Collins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/55B795C4-621C-41B7-8489-FDF214BD3B8E"><gtr:id>55B795C4-621C-41B7-8489-FDF214BD3B8E</gtr:id><gtr:firstName>J?rgen</gtr:firstName><gtr:surname>Roes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9B8AD86D-047F-4ED8-9132-A04425B9A510"><gtr:id>9B8AD86D-047F-4ED8-9132-A04425B9A510</gtr:id><gtr:firstName>Wendy</gtr:firstName><gtr:surname>Barclay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C79F2084-3844-4F18-BB91-8CF3F33A1361"><gtr:id>C79F2084-3844-4F18-BB91-8CF3F33A1361</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Seton</gtr:otherNames><gtr:surname>Tedder</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5CCB64D5-FCBB-4CC6-B9E4-F3D4B42E53BB"><gtr:id>5CCB64D5-FCBB-4CC6-B9E4-F3D4B42E53BB</gtr:id><gtr:firstName>Deenan</gtr:firstName><gtr:surname>Pillay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/36906F8E-5D84-4FA7-A29C-914D210CD13F"><gtr:id>36906F8E-5D84-4FA7-A29C-914D210CD13F</gtr:id><gtr:firstName>Duncan</gtr:firstName><gtr:surname>Clark</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/60A6B3BA-CD5D-4C79-B4A6-327FF39DE1AB"><gtr:id>60A6B3BA-CD5D-4C79-B4A6-327FF39DE1AB</gtr:id><gtr:firstName>Ariberto</gtr:firstName><gtr:surname>Fassati</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8EEFEE58-E369-4F4C-86BF-3AAE616C59E5"><gtr:id>8EEFEE58-E369-4F4C-86BF-3AAE616C59E5</gtr:id><gtr:firstName>Tim J</gtr:firstName><gtr:surname>Harrison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C8928265-0C59-49F5-95D1-5CD184FBEF8B"><gtr:id>C8928265-0C59-49F5-95D1-5CD184FBEF8B</gtr:id><gtr:firstName>Benny</gtr:firstName><gtr:surname>Chain</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/365B37B6-7E8D-4B2E-A39D-02E92F44F91E"><gtr:id>365B37B6-7E8D-4B2E-A39D-02E92F44F91E</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Boshoff</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3A2D1CFF-D14D-409F-8B2F-D87FFE363AF2"><gtr:id>3A2D1CFF-D14D-409F-8B2F-D87FFE363AF2</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:surname>Weiss</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4342E52F-F544-423C-A7B1-7CDB0D7EB5E0"><gtr:id>4342E52F-F544-423C-A7B1-7CDB0D7EB5E0</gtr:id><gtr:firstName>R</gtr:firstName><gtr:surname>Coffin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/ED7DFA83-26A3-4280-9A85-FEFBEF19AB03"><gtr:id>ED7DFA83-26A3-4280-9A85-FEFBEF19AB03</gtr:id><gtr:firstName>Aine</gtr:firstName><gtr:surname>McKnight</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4CE725D8-3664-490D-85FF-36DCE66B3262"><gtr:id>4CE725D8-3664-490D-85FF-36DCE66B3262</gtr:id><gtr:firstName>Vincent</gtr:firstName><gtr:surname>Emery</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9721629"><gtr:id>8EBEE230-316B-455B-B3BC-FDA8F3AC4DA1</gtr:id><gtr:title>UCL Centre for Medical Molecular Virology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9721629</gtr:grantReference><gtr:abstractText>Persistent viral disease is a significant problem in the UK. 30,000 people are estimated to be living with HIV-1, the virus that causes AIDS and 50,000 people are carriers of hepatitis B, which causes chronic liver disease. Viral infection also hampers advanced medical technologies, such as bone marrow or liver transplantation. This Centre proposal aims to link groups working on basic virus biology, the response of patients to viruses and the development of new viral diagnostics and treaments.</gtr:abstractText><gtr:technicalSummary>The applicants aim to pursue their current peer-reviewed research programmes, with collaborations enhanced by the Medical Molecular Virology Centre. 
Our efforts are focused on persistent, pathogenic, human viral disease and we study:
(i) Virus/cell interactions: identification and study of cellular pathways involved in viral infection and oncogenesis.
(ii) Virus/host interactions: identification and study of pathways involved in viral immunity and pathogenesis. 
(iii) Translational research: learning facets of basic virology from clinical studies and applying basic knowledge from the above programmes to improve diagnosis and treatment.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-23</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>927754</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Adrian Hill and Helen McShane Oxford supported by UCL CBRC grant (COLLINS)</gtr:description><gtr:id>D8618945-43DB-47C2-9B44-2FA4109D7913</gtr:id><gtr:impact>in progress</gtr:impact><gtr:partnerContribution>Novel adjuvant molecules, TB antigens and models</gtr:partnerContribution><gtr:piContribution>Lentiviral vectors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Hebrew University of Jerusalem</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:department>Weizmann Institute of Science</gtr:department><gtr:description>Population dynamics of T cell responses analysed using high-throughput sequencing of TCR repertoire (CHAIN)</gtr:description><gtr:id>8DB6149B-22E2-42E6-B504-694392F1B332</gtr:id><gtr:impact>Still in progress</gtr:impact><gtr:partnerContribution>Immunisations and seqeuncing</gtr:partnerContribution><gtr:piContribution>Developemnt of software for seqeunce analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biodim Laboratory</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Discovery of new cellular targets for antiretroviral drug development (FASSATI)</gtr:description><gtr:id>7B253507-36FC-4E19-9F4A-097EDBE189A5</gtr:id><gtr:impact>Eleven new hits identified to be followed up</gtr:impact><gtr:partnerContribution>Provided chemical library of 10,000 compounds to perform screening and cherry picked compounds.</gtr:partnerContribution><gtr:piContribution>Developed a novel cell-based, high through put screening assay. Discovered a new cell target important for HIV-1 infection.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>University College London (UCL), UCL Cancer Institute</gtr:department><gtr:description>National Facility for GMP production of lentiviral and AAV vectors for gene therapy (MARY COLLINS)</gtr:description><gtr:id>4B49FFE8-AC67-42CF-BB98-5DBF0CA6BA3A</gtr:id><gtr:impact>in progress (publications)</gtr:impact><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Metbolism and Endocrinology</gtr:department><gtr:description>Dr Richard Benarous, Mutabilis, France</gtr:description><gtr:id>E6538DDD-0612-47B6-BC58-0F9D44700E8E</gtr:id><gtr:impact>Identified four new compounds with antiretroviral activity: they belong to a new class of antiretrovirals .</gtr:impact><gtr:partnerContribution>Provided expertise and library of 10,000 small chemical compounds selected from a 150,000 compounds library.</gtr:partnerContribution><gtr:piContribution>Performed novel high through put screening to identify host factos necessary for HIV-1 replication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Infection &amp; Immunity</gtr:department><gtr:description>Ari Fassati collaboration (R JENNER)</gtr:description><gtr:id>D222FF95-2823-4C7A-AB52-C563A3B0F6C1</gtr:id><gtr:impact>na</gtr:impact><gtr:partnerContribution>resulting in publication 20937817</gtr:partnerContribution><gtr:piContribution>intellectual input into research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Llama VHHantobody fragments to neutralise viruses (WEISS)</gtr:description><gtr:id>258649C5-FAA3-49E9-8A7D-F9F64E2BE944</gtr:id><gtr:impact>Research papers and 1 patent filed</gtr:impact><gtr:partnerContribution>VHH technology</gtr:partnerContribution><gtr:piContribution>virology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>12D80D4E-CDE7-4654-BA1A-31BABB16FAE4</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Christopher Moody and Dr Russell Kitson, University of Nottingham</gtr:description><gtr:id>5A89993D-C6D7-417F-AFA7-27FF3E9B106B</gtr:id><gtr:impact>One paper in PNAS</gtr:impact><gtr:partnerContribution>Provided new chemical compounds inhibitors of Hsp90</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 latency.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Professor Olivier Schwartz, Pasteur Institute, Paris</gtr:description><gtr:id>33DFAD7E-3223-46E1-8EB7-6A47B09FA56C</gtr:id><gtr:impact>One paper in PLoS Pathogens describing the effect of fever on HIV-1 replication and the role of Hsp90</gtr:impact><gtr:partnerContribution>Provided data and expertise on mechanisms contributing to enhanced HIV-1 replication during hyperthermia (fever).</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre</gtr:department><gtr:description>MRC Clinical Sciences Centre (R JENNER)</gtr:description><gtr:id>92BA99C4-87C6-40B0-AF04-409522ED4B6B</gtr:id><gtr:impact>In progress</gtr:impact><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Charles Bangham, Imperial College</gtr:description><gtr:id>2E79E9B6-E6C9-4211-AD01-206056DDC7BE</gtr:id><gtr:impact>One paper in preparation, one grant application submitted to MRC.</gtr:impact><gtr:partnerContribution>High through put sequencing of HIV-1 integration sites.</gtr:partnerContribution><gtr:piContribution>Discovered new host factor involved in HIV-1 replication that affects integration site selection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Peter Cherepanov, CRUK</gtr:description><gtr:id>E9DEF2D2-7159-44FB-8AAB-E7956444ACDA</gtr:id><gtr:impact>One paper in PNAS</gtr:impact><gtr:partnerContribution>Structural biology of transportin 3.</gtr:partnerContribution><gtr:piContribution>provision of expression constructs recomninat protein expression and methods for immunoprecipitation. Expertise on nuclear transport receptors.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Medicine</gtr:department><gtr:description>UCL Dept Medicine (R JENNER)</gtr:description><gtr:id>4785760A-DDD9-4D0F-9DE2-85B7989D0C4E</gtr:id><gtr:impact>In progress</gtr:impact><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Discovery of new cellular targets for antiretroviral drug development (FASSATI)</gtr:description><gtr:id>4910F2B3-8445-48D7-91C2-17F15A8EA7EF</gtr:id><gtr:impact>in the process of testing the compounds</gtr:impact><gtr:partnerContribution>Provided novel lead compounds that inhibit the target identified in our high through put screening</gtr:partnerContribution><gtr:piContribution>Developed a novel high through put screening, cell-based assay. Discovered a new cell target important for HIV</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>London Centre for Nanotechnology</gtr:department><gtr:description>Mechanism of viral transport across nuclear pores (FASSATI)</gtr:description><gtr:id>76E450D4-05B5-46A6-A411-A639FCA67643</gtr:id><gtr:impact>One modelling paper (Phys. Rev. E. 2012), one review (Soft Matter 2013), one paper to be submitted shortly.</gtr:impact><gtr:partnerContribution>Atomic force microscopy and physical modelling of nuclear pores.</gtr:partnerContribution><gtr:piContribution>Expertise on nucleo-cytoplasmic trafficking of viruses and large molecules.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Sanger Centre collaboration (DAN DEPLEDGE)</gtr:description><gtr:id>E4637826-D5E0-44EC-A2E8-99E7AB980DA0</gtr:id><gtr:impact>In progress</gtr:impact><gtr:partnerContribution>Shared knowledge, materials and resources leading to publication output (in progress)</gtr:partnerContribution><gtr:piContribution>Shared knowledge, materials and resources leading to publication output (in progress)</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Whitehead Institute for Biomedical Research</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Whitehead Inst Biomed Res (R JENNER)</gtr:description><gtr:id>6FBC2B26-EC03-4F09-AC17-48C1F55DA747</gtr:id><gtr:impact>In progress</gtr:impact><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Infection &amp; Immunity</gtr:department><gtr:description>Novel broadly neutralizing Llama VHH (FASSATI)</gtr:description><gtr:id>62F10CA9-A930-4BC5-91F1-20A26338AB2E</gtr:id><gtr:impact>One paper to be submitted shortly.</gtr:impact><gtr:partnerContribution>Characterised VHH, area of binding, performed deep sequencing to demonstrate that novel VHH arised after immunization.</gtr:partnerContribution><gtr:piContribution>Developed and performed high through put screening to identify novel broadly neutralizing LLama VHH, identified three new VHH.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>London Centre for Nanotechnology</gtr:department><gtr:description>London Centre for Nanotechnology (A FASSATI)</gtr:description><gtr:id>D89449FB-552C-40DB-A8CE-6BAB037C6FDA</gtr:id><gtr:impact>a shared IMPACT PhD studentship for Dino Osmanovic</gtr:impact><gtr:piContribution>Collaboration with the London Centre for Nanotechnology (Bart Hoogemboom and Ian Ford), which resulted in a shared IMPACT PhD studentship for Dino Osmanovic</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Mike Stratton and Dr Elisabeth Murchison, Wellcome Trust Sanger Institute</gtr:description><gtr:id>FCDC48E3-38B5-458D-B1C4-2616D6E6F7E7</gtr:id><gtr:impact>A paper describing the CTVT genome published in Science, another publication on the tumour transcriptional changes is in preparation.</gtr:impact><gtr:partnerContribution>Provided data and expertise on the genome of CTVT</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the canine Venereal Transmissible Tumour (CTVT).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Centre for Genetic Engineering and Biotechnology (ICGEB)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>CF9430F7-DD33-4BA3-8FA2-28DA8CAAE795</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Marcus Dorner, Imperial College</gtr:description><gtr:id>FA0FF4A4-E789-4595-A1E4-48F49243CE3E</gtr:id><gtr:impact>experiments ongoing</gtr:impact><gtr:partnerContribution>Humanized mouse models for HIV-1 infection to test the effect of selective Hsp90 inhbitors on HIV-1 latency.</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the effect of Hsp90 on regulation of HIV-1 latency, provided specific Hsp90 inhibitor.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>KCL Paul Lavender (R JENNER)</gtr:description><gtr:id>DFA6B17D-79C1-43FA-B299-A2270C24FA47</gtr:id><gtr:impact>resulting in publication 21876034</gtr:impact><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Raymond Welsh Lab Visit (PEPPA)</gtr:description><gtr:id>7829973A-7075-410B-9042-4A5E155717B3</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:partnerContribution>development of valuable collaboration, also link with a planned project on regulatory potential of NK cells in HBV with the MRC unit in the Gambia</gtr:partnerContribution><gtr:piContribution>address how T cell regulation by NK cells contribute to overall disease pathogenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Prof. Olivier Schwartz, Pasteur Institute, Paris (FASSATI)</gtr:description><gtr:id>88B163AF-878A-4446-BF21-29D201746FCD</gtr:id><gtr:impact>One paper in PLoS Pathogens describing the effect of fever on HIV-1 replication and the role of Hsp90</gtr:impact><gtr:partnerContribution>Provided data and expertise on mechanisms contributing to enhanced HIV-1 replication during hyperthermia (fever)</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Restriction Factor Structure Function</gtr:description><gtr:id>C3421ACC-A733-42AD-B7CC-60E30D76EA5F</gtr:id><gtr:impact>We have copublished PMIDs 21045130, 20808866, 19767750, 19073742
Collaboration is multidiciplinary in that we are molecular virologists and James is a biophysicist and protein crystallographer</gtr:impact><gtr:partnerContribution>The James lab has solved crystal structures of restriction factors and viral proteins and performed many biophysical and chemistry experiments allowing us to understand the mechanistic details of restriction factor virus interactions.</gtr:partnerContribution><gtr:piContribution>We have characterised host restriction factor relationships and evolution by collaborating with Leo James at the laboratory for Molecular Biology. Leo solves structures and performs biophysical measurements of protein/protein interactions and we characterise and assay mutant behavior thereby learning mechanistic molecular details of action and evolution.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Scripps Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dennis Burton Lab Visit (MCCOY)</gtr:description><gtr:id>A8B08130-BAB3-41F9-96EF-552DA1AFB064</gtr:id><gtr:impact>not known yet</gtr:impact><gtr:partnerContribution>This travel grant was used to accelerate a HIV antigen development project</gtr:partnerContribution><gtr:piContribution>This travel grant was used to accelerate a HIV antigen development project</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC UCL Centre for Medical Molecular Virology</gtr:department><gtr:description>Professor Benny Chain, UCL and MRC Centre</gtr:description><gtr:id>34767B50-4558-4267-8B0B-34AAB52CF5D1</gtr:id><gtr:impact>One MSc Thesis (Tse Wang) and one paper published in the journal Traffic</gtr:impact><gtr:partnerContribution>Provided data and expertise on biophysical properties of transfected DNA and on innate Immunity.</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on nuclear import of DNA.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Infection &amp; Immunity</gtr:department><gtr:description>UCL Paul Kellam (R JENNER)</gtr:description><gtr:id>D6E0E3BD-400D-4F29-A860-2236671E14B2</gtr:id><gtr:impact>awarded a grant of &amp;pound;99,940, outcomes (published material etc) yet to be recorded.</gtr:impact><gtr:piContribution>Collaboration with Paul Kellam resulting in a project grant from the UCLH/UCL Comprehensive Biomedical Research Centre.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Understanding the coordination of hepatitis C virus entry and humoral immune evasion (GROVE)</gtr:description><gtr:id>7CADE087-B1D4-45B0-8509-92E58DF7E2A5</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:partnerContribution>Access to clinical samples</gtr:partnerContribution><gtr:piContribution>Project conception, development and application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of W?rzburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Wuerzburg Collaboration (STAUSS)</gtr:description><gtr:id>BCB9795E-8373-489E-BE0E-5A96E53E8BC2</gtr:id><gtr:impact>TBA</gtr:impact><gtr:partnerContribution>TBA</gtr:partnerContribution><gtr:piContribution>TBA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Biosciences</gtr:department><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>5E366C2F-2050-48CB-9395-FC095D39C067</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Super-resolution imaging: probe development (GROVE)</gtr:description><gtr:id>63279F8C-DD2D-4D57-9FF7-E117E4FDA5D7</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:partnerContribution>Project conception, development and application</gtr:partnerContribution><gtr:piContribution>Project conception, development and application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biomedical NMR Centre at NIMR</gtr:department><gtr:description>Dr. Ian Taylor, MRC NIMR, Mill Hill (FASSATI)</gtr:description><gtr:id>F44226EF-173E-4D92-97D5-032A46FB1A92</gtr:id><gtr:impact>one paper in preparation</gtr:impact><gtr:partnerContribution>co-crystal structure of Coumermycin-A1 and HIV-1 capsid protein</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of the antibiotic Coumermycin-A1 in blocking HIV-1 replication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Veronique Birault, GSK, Stevenage.</gtr:description><gtr:id>75DF124F-7FB1-4226-8BE4-38103EB9EDCB</gtr:id><gtr:impact>In the process of performing SAR studies with GSK compounds</gtr:impact><gtr:partnerContribution>Provided lead compounds that target the new host factor discovered by us.</gtr:partnerContribution><gtr:piContribution>Provided data on a new host factor to be used as an antiretroviral target.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Hebrew University of Jerusalem</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:department>Weizmann Institute of Science</gtr:department><gtr:description>WESTON VISITING PROFESSORSHIP (BENNY CHAIN)</gtr:description><gtr:id>4C09B183-0A60-4C9C-9DD1-A6076714A519</gtr:id><gtr:impact>Led to award of a bilateral Weizmann/UCL grant (Making Connections programme) $100,000 over two years.</gtr:impact><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit, London (3 visits)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D1A5FCDB-0EAF-49F2-A031-95F110C01256</gtr:id><gtr:impact>50+ 6th form Biology students attended a talk given by Prof Mary Collins on both Virology and science careers.

Provided further insights to virology and encouraged studetns further in choosing scientific careers</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture on the AIDS epidemic for the charity &quot;Mothers to Mothers&quot; London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4F3BB8A2-24A2-4D9E-8FC2-556FFA62FFFA</gtr:id><gtr:impact>to be added</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.m2m.org</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Immunity and Transplantation Opening Symposium (GROVE)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0B14C585-4AD5-40AF-830C-73982680BC63</gtr:id><gtr:impact>The symposium was filmed and I worked with a video editor to create a digital version of the presentation for You Tube</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Observer Interview (M COLLINS)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>1066CB06-9609-4811-BC7E-DE502C998A87</gtr:id><gtr:impact>&amp;quot;My Bright Idea&amp;quot;- Interview for The Observer, 24/4/11

na</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contribution to the Financial Times &quot;New synthetic life needs context and regulation&quot;(A. Fassati)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>677B609B-A475-448D-9BBD-9AC8043666FB</gtr:id><gtr:impact>to be added</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.ft.com/cms/s/0/3da6db20-6796-11df-a932-00144feab49a.html#axzz2hsOEkNfY</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayflower &amp; Gayhurst Primary schools visits 2012 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CADCFF93-E99F-470B-9928-422D7DA69A3F</gtr:id><gtr:impact>Centre members visited local schools and presented an interactive talk about virology. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture &quot;Conscience and values in the response to infectious diseases&quot;, Thomas More Institute, London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>26E1F9C6-1F1C-4D67-9472-88923D979D46</gtr:id><gtr:impact>to be added</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://thomasmoreinstitute.org.uk/papers/conscience-and-values-in-the-response-toinfectious-diseases/</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lunchtime Lecture UCL (COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>59FD0DB1-EE1C-461A-910B-C7E478B9619B</gtr:id><gtr:impact>800 You tube hits</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Arts talk (M COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>7239351F-C201-40AC-8E10-BD54171AD0FD</gtr:id><gtr:impact>presented talk titled 'Are Women Changing Science?'

na</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture: City of London Boyrs School (B CHAIN)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>761188F8-F1AE-4F02-9777-3923CA9BA71D</gtr:id><gtr:impact>50+ pupils attended a lecture titled 'vaccinations'

na</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk in Bloomsbury Festival (M COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8D28D840-202A-4978-9C1A-04481BE8C231</gtr:id><gtr:impact>Cosy Science, &amp;quot;viruses are our friends&amp;quot;, The Marquis of Cornwallis pub, 2013 for 50+ local residents

raised public awareness</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience pupils (x4)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>80A324BC-6D0B-4D10-B411-F52985B86275</gtr:id><gtr:impact>high school students attending 1 week work experience placements in various member's labs; shadowing staff and performing experiments

Provided further encouragement to take further study/career directions in virology or biomedical sciences</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Carolton Primary School Visit 2012 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8CE0C7DF-64B8-4BC0-9713-1352A03215FE</gtr:id><gtr:impact>40 local school children attended open day in the Centre labs; consisted of interactive introductory talk, followed by lab rotations where pupils preformed DNA extractions, microscope work, pipetting skills, artwork. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HIV &amp; AIDS (WEISS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>03A57466-E01B-44B2-AB76-16C3850298BE</gtr:id><gtr:impact>too soon to say</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Thomas More Institute talk (A FASSATI)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>07F975BE-B4F2-4E02-88E7-39AF91166D8E</gtr:id><gtr:impact>presented talk titled 'Conscience and Values in the Response to Infectious Diseases' given to 50+ adult members of the public

na</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Live comment on the origin of the AIDS epidemic on Arise News (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CAEAB166-58CF-4F9E-BF4F-1168B7282D5E</gtr:id><gtr:impact>to be added</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.arise.tv/arise-news-show/africa-wrap-03-10-8501</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Y6 children &quot;Investigating microbes&quot; at the Oratory RC Primary School, London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FEA727CF-C3D3-43EE-A0A1-8BE8FF7D0FE6</gtr:id><gtr:impact>to be added</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (x2), 2011</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>DE377A62-C197-4664-92C3-8FD3FD12E33E</gtr:id><gtr:impact>R Milne &amp;amp; G Towers visited 2 primary schools (Gayhurst and Mayflower), various activities for 50+ pupils

received many thank you letters and further questions from pupils</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture (STAUSS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D6920304-0D9F-40BB-9E95-CFA49E12B688</gtr:id><gtr:impact>Approximately 200 lay people attended lecture on T Cell therapy

Lecture was recorded and is available on You-tube</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit Primrose Hill (STAUSS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>99849A07-25B2-45B7-998C-4E4B1D22AB59</gtr:id><gtr:impact>Parents attended a presentation of our research and all children attended an assembly

money raised for cancer research</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC@UCL Centenary Science Fair (ALL MEMBERS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E73B534D-9164-4BF0-8733-2251450C23E8</gtr:id><gtr:impact>500+ members of the public (families, adults, school children) attended a science fair held @ UCL, Centre members contributed 3 hands-on workshop stalls, and presented separate talks. The public were given opportunities to perform tasks associated with the work of the Centre, and asked questions/contributed to discussions about what the Centre does and general science queries. Feedback included saying children had increased interest in developing their science education and awareness of virology principles.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayflower &amp; Gayhurst Primary School visits 2013 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A87DBB34-0963-4275-BCB5-098070217FFA</gtr:id><gtr:impact>Centre members visited local schools and presented an interactive talk about virology. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>mothers2mothers charity talk (A FASSATI)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8B49DE7A-0DB1-4524-9B35-5122B9AE665A</gtr:id><gtr:impact>presented talk titled 'The Current AIDS Epidemic' to 25+ members of the adult public

all proceeds to mothers2mothers charity</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Social Mobility Foundation Students (G TOWERS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>DA877E15-6BE1-48E6-8234-01507AF93746</gtr:id><gtr:impact>We took 2 students for a week each in August.

The idea is that students from poor backgrounds who wouldnt normally be exposed to opportunities for work experience can be helped out.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship (MARY COLLINS)/University College London</gtr:description><gtr:end>2009-02-02</gtr:end><gtr:fundingOrg>University College London (UCL)</gtr:fundingOrg><gtr:id>606F86F7-E993-433A-9058-0C3FA35ADC02</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7 HEALTH 2012 INNOVATION-1 (STAUSS)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>0AA7131A-4D9F-48C9-9AFD-68539A34EFDC</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PROJECT GRANT (BENNY CHAIN)/GATES FOUNDATION GRAND CHALLENGE GRANT</gtr:description><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>5C220F9A-CA29-4F29-BEEB-255C0BF40535</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>237518</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (R JENNER)</gtr:description><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>D49C4F1E-6886-4C9A-8F39-CFAF539078F8</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>37500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LupusUK Consumables Fund (R JENNER)/LupusUK</gtr:description><gtr:fundingOrg>LUPUS UK</gtr:fundingOrg><gtr:id>26581AEC-7FAE-4DCE-B649-1C025CF94BC1</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Rosetrees: relationship between vitamin D deficiency and the immune response (B CHAIN)</gtr:description><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>6B0BFBCA-DF4A-46D8-A1ED-A693B6D264F7</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK research grant (M COLLINS)</gtr:description><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>8E140308-2811-495B-B244-4BEAB2DF35D2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - Khaled Sanber (M COLLINS)</gtr:description><gtr:fundingOrg>University College London (UCL)</gtr:fundingOrg><gtr:id>F2A8F43D-9A9B-4001-AE71-0CCD9329C1C0</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London</gtr:department><gtr:description>CBRC grant award CBRC grant Measuring T cell repertoire perturbation in HIV infection (B CHAIN)</gtr:description><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>CFE799C6-4B02-4426-A316-D21EBF3947D8</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50711</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long-Term Fellowship (R JENNER)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation (EMBO)</gtr:fundingOrg><gtr:id>0BAE8ED7-A3CC-4E10-BB8A-2B10F8609469</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140888</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London</gtr:department><gtr:description>Biomedical Research Centre research grant (M COLLINS)</gtr:description><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>D5424557-40CD-4121-8686-1A5E2AA8E022</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1559842</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Research Fellowship in basic biomedical science</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>945EA681-1DAC-4A0D-95B2-B27EA182040C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>520000</gtr:amountPounds><gtr:country>Hungary, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Biological Research Centre (BRC)</gtr:department><gtr:description>UCLH BRC Funding for Wolfson Gene Therapy Unit, 2013-2016 (M. Collins)</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Hungarian Academy of Sciences (MTA)</gtr:fundingOrg><gtr:id>7A8D15FC-6183-405A-8174-A750AB9B9EAF</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>NA</gtr:description><gtr:id>E26DB3A7-E2EA-4DBE-BF19-99A330414922</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>GB1015305.4</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>patent application # 1015305.4 (R JENNER)</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SAB CIRI, Lyon (M COLLINS)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>4E040CCF-7813-4F67-A79C-C940282412FA</gtr:id><gtr:impact>improved research practices at CIRI</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Unilver sponsored workshop (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>CE81A4F4-E6C6-432B-B914-59CDAD65400B</gtr:id><gtr:impact>Invited planer speaker for 'T-lymphocytes: Orcehstrators of skin sensitisation'.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of DH Gene and Stem Cell therapy advisory committee (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>1ACB4FBE-D1BA-4986-8E21-A6D52A2D392D</gtr:id><gtr:impact>Provides advice on policy and safety at national level</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>'Bench to Bedside' PhD programme (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>4B851CFB-B3B1-47AF-A791-D575FA45AF2F</gtr:id><gtr:impact>Newly established studentship scheme providing translational context for basic sceince PhDs in area of Infection &amp;amp; Immunity</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>INSERM lentiviral vector course (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>C6F5FF41-C5B1-4338-BC70-5452A9FD7DFD</gtr:id><gtr:impact>Provided advancement of training in this area to postgraduate+ level audiences</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member sub-panel 1, REF (M COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>73E637B3-4818-44B3-A406-D9452DB22783</gtr:id><gtr:impact>contribution to determining research standards of national institutes</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EMBO course (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>BCC7EA88-5752-4EE0-AF63-93E7ECD5576F</gtr:id><gtr:impact>Provided advancement of training in this area to postgraduate+ level audiences</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>FSA-MRC joint workshop (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>65B8C295-F02D-42A8-B73F-27D31E8D542A</gtr:id><gtr:impact>Participant in owrkshop which promotes opportunities for synergy between basic immunology and food allergy research</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SAB Heinrich Pette Institute (M COLLINS)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>287B2850-E63A-4943-9329-FA41EAFBBF14</gtr:id><gtr:impact>improved research practices at the Institute</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Analysis pipeline for ChIP-Seq data</gtr:description><gtr:id>8C35C121-DF4C-48AD-A69B-1495C5D0E149</gtr:id><gtr:impact>Aid the research of own and other groups in this field, useful resource tool</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Analysis pipeline for ChIP-Seq data (R JENNER)</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mouse gene knockout of cathepsin E (aspartic proteinase involved in immune function)</gtr:description><gtr:id>47C909E3-E92F-4D21-B4FC-456997789C71</gtr:id><gtr:impact>offers the opportunity for further studies of cathepsin E in vivo based on this mouse model</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mouse gene knockout cathepsin E (BENNY CHAIN)</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Database short RNAs transcribed in CD4+ T-cells</gtr:description><gtr:id>5396F283-44A7-4DAF-B106-873D65F5F381</gtr:id><gtr:impact>Aid the research of own and other groups in this field, useful resource tool</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Database short RNAs transcribed in CD4+ T-cells (R JENNER)</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF6F1394-8D7B-4C52-8C07-3E098466919D"><gtr:id>DF6F1394-8D7B-4C52-8C07-3E098466919D</gtr:id><gtr:title>Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b3a3adedd0a4c591c660bb492c735948"><gtr:id>b3a3adedd0a4c591c660bb492c735948</gtr:id><gtr:otherNames>Alpizar YA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AAD43671-F9CB-40D7-BA77-7D95328D6945"><gtr:id>AAD43671-F9CB-40D7-BA77-7D95328D6945</gtr:id><gtr:title>Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/303c119beb542abcde81d023f6f3fef2"><gtr:id>303c119beb542abcde81d023f6f3fef2</gtr:id><gtr:otherNames>Keckesova Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D738685C-CB02-44E5-AFBA-152502B11D73"><gtr:id>D738685C-CB02-44E5-AFBA-152502B11D73</gtr:id><gtr:title>Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissues.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02766ea99fdc02271ba31905900e4123"><gtr:id>02766ea99fdc02271ba31905900e4123</gtr:id><gtr:otherNames>Ferguson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57639518-B6D9-4B6A-81B9-7B2A420A5677"><gtr:id>57639518-B6D9-4B6A-81B9-7B2A420A5677</gtr:id><gtr:title>Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/16e46d4f7f3d0fd5771d96152a22af04"><gtr:id>16e46d4f7f3d0fd5771d96152a22af04</gtr:id><gtr:otherNames>Blondeau C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97B84E06-7BB3-4F8F-ADBE-AE4B102D0519"><gtr:id>97B84E06-7BB3-4F8F-ADBE-AE4B102D0519</gtr:id><gtr:title>A lentiviral vector pseudotype suitable for vaccine development.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6d7ce540024a50b8bd8ff7d2427850e4"><gtr:id>6d7ce540024a50b8bd8ff7d2427850e4</gtr:id><gtr:otherNames>Lopes L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/492131E1-29FB-4882-A0C7-C5027334F0AE"><gtr:id>492131E1-29FB-4882-A0C7-C5027334F0AE</gtr:id><gtr:title>HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfe8677cb938dc1232570dc209d4c71e"><gtr:id>cfe8677cb938dc1232570dc209d4c71e</gtr:id><gtr:otherNames>Tsang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0749A5D3-A452-4284-B706-56CE3C759BE3"><gtr:id>0749A5D3-A452-4284-B706-56CE3C759BE3</gtr:id><gtr:title>Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D6754ADE-39CA-4A8F-BCD2-9AF65DDDF751"><gtr:id>D6754ADE-39CA-4A8F-BCD2-9AF65DDDF751</gtr:id><gtr:title>HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ede923f969c5ec692b719203d38f9dc6"><gtr:id>ede923f969c5ec692b719203d38f9dc6</gtr:id><gtr:otherNames>Ocwieja KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BB8582F2-11AC-49E3-95E8-FB744E36FD6A"><gtr:id>BB8582F2-11AC-49E3-95E8-FB744E36FD6A</gtr:id><gtr:title>Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9db46c5b7405794c0889d48fee503e50"><gtr:id>9db46c5b7405794c0889d48fee503e50</gtr:id><gtr:otherNames>Petit SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FD8A34A-3157-4C52-99EB-07E43FEB07C9"><gtr:id>7FD8A34A-3157-4C52-99EB-07E43FEB07C9</gtr:id><gtr:title>Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/12739F3D-5CF2-4E24-952F-946FEC7C0048"><gtr:id>12739F3D-5CF2-4E24-952F-946FEC7C0048</gtr:id><gtr:title>Adherent human alveolar macrophages exhibit a transient pro-inflammatory profile that confounds responses to innate immune stimulation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/95729c2d3a47703ec5f65134a7553513"><gtr:id>95729c2d3a47703ec5f65134a7553513</gtr:id><gtr:otherNames>Tomlinson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97B41ACD-0221-4AAC-A2B9-FFA40E5F96E0"><gtr:id>97B41ACD-0221-4AAC-A2B9-FFA40E5F96E0</gtr:id><gtr:title>Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21).</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c71af6e6a5f6449faafda0c5b494a1f3"><gtr:id>c71af6e6a5f6449faafda0c5b494a1f3</gtr:id><gtr:otherNames>Mallery DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3FB5E17F-0364-42BD-A4B7-E203B21B4C6E"><gtr:id>3FB5E17F-0364-42BD-A4B7-E203B21B4C6E</gtr:id><gtr:title>The impact of DNA topology on polyplex uptake and transfection efficiency in mammalian cells.</gtr:title><gtr:parentPublicationTitle>Journal of biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6957c278545d5de8c579b913a19c47c3"><gtr:id>6957c278545d5de8c579b913a19c47c3</gtr:id><gtr:otherNames>Dhanoya A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1656</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79EA53FD-13BE-4941-8FF0-C9893FDECA9C"><gtr:id>79EA53FD-13BE-4941-8FF0-C9893FDECA9C</gtr:id><gtr:title>IL15 can reverse the unresponsiveness of Wilms' tumor antigen-specific CTL in patients with prostate cancer.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/107069b077fbb6c4b8941b9da67b7b94"><gtr:id>107069b077fbb6c4b8941b9da67b7b94</gtr:id><gtr:otherNames>King JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6D6E5099-8282-42AC-ACC8-8B1BCF6822CB"><gtr:id>6D6E5099-8282-42AC-ACC8-8B1BCF6822CB</gtr:id><gtr:title>SAMHD1-dependent retroviral control and escape in mice.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F30DD958-205B-4F1E-9F36-3C12AB5B8862"><gtr:id>F30DD958-205B-4F1E-9F36-3C12AB5B8862</gtr:id><gtr:title>Ovine TRIM5a can restrict visna/maedi virus.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5657dc368990f3b9334380f063e243aa"><gtr:id>5657dc368990f3b9334380f063e243aa</gtr:id><gtr:otherNames>J?uregui P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5996277-D796-4832-8E0B-7BA1DCCDC2B8"><gtr:id>C5996277-D796-4832-8E0B-7BA1DCCDC2B8</gtr:id><gtr:title>Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f89c7b4622f2153cac81da53204ade0e"><gtr:id>f89c7b4622f2153cac81da53204ade0e</gtr:id><gtr:otherNames>Chan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/873E228C-E24A-4526-B40F-5908CDAA8F76"><gtr:id>873E228C-E24A-4526-B40F-5908CDAA8F76</gtr:id><gtr:title>HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c1631b90dc75345cf78ba845c220f14"><gtr:id>9c1631b90dc75345cf78ba845c220f14</gtr:id><gtr:otherNames>Breckpot K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66663520-F990-4562-BBC3-430FEBF4DCD9"><gtr:id>66663520-F990-4562-BBC3-430FEBF4DCD9</gtr:id><gtr:title>HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b80e4206e65c27027c5eb4c5816ed08"><gtr:id>2b80e4206e65c27027c5eb4c5816ed08</gtr:id><gtr:otherNames>Schaller T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D5E49E4-BD09-42F4-9D6B-C4BFA5C2491D"><gtr:id>7D5E49E4-BD09-42F4-9D6B-C4BFA5C2491D</gtr:id><gtr:title>Chemical toxicity to keratinocytes triggers dendritic cell activation via an IL-1a path.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42d8c6ca8786a190e5c6d4f3de1426de"><gtr:id>42d8c6ca8786a190e5c6d4f3de1426de</gtr:id><gtr:otherNames>Matjeka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF36DA85-2598-4A11-A59A-C029CDAD1BA3"><gtr:id>EF36DA85-2598-4A11-A59A-C029CDAD1BA3</gtr:id><gtr:title>From Duke to King's: Michael Malim wins the 2010 Retrovirology Prize.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6477298E-A163-42F1-8785-0CCBBFF44A3C"><gtr:id>6477298E-A163-42F1-8785-0CCBBFF44A3C</gtr:id><gtr:title>Development of an Escherichia coli expressing listeriolysin-O vaccine against Wilms tumor gene 1-expressing tumors.</gtr:title><gtr:parentPublicationTitle>Journal of immunotherapy (Hagerstown, Md. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49a790dd5935ea90a9bd132b1df62812"><gtr:id>49a790dd5935ea90a9bd132b1df62812</gtr:id><gtr:otherNames>Dai MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1524-9557</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6D9C0E81-BF6A-4EA3-A81F-AD1F14D22E20"><gtr:id>6D9C0E81-BF6A-4EA3-A81F-AD1F14D22E20</gtr:id><gtr:title>Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/41d7ef596be4b3c17e86a591d669f56b"><gtr:id>41d7ef596be4b3c17e86a591d669f56b</gtr:id><gtr:otherNames>Wright GP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/81A39933-3631-4467-B6BD-58C1C74D3A3F"><gtr:id>81A39933-3631-4467-B6BD-58C1C74D3A3F</gtr:id><gtr:title>Immunomodulation in the treatment of haematological malignancies.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a76e897c6e4a3f2ef62352c6e32d06d"><gtr:id>4a76e897c6e4a3f2ef62352c6e32d06d</gtr:id><gtr:otherNames>Cesco-Gaspere M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1591-8890</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9190C1F7-AE91-4D4E-A588-3C68540C64A4"><gtr:id>9190C1F7-AE91-4D4E-A588-3C68540C64A4</gtr:id><gtr:title>Comparison of lentiviral and sleeping beauty mediated a? T cell receptor gene transfer.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/650f1d8cfe4962f9cd8bede5aa155319"><gtr:id>650f1d8cfe4962f9cd8bede5aa155319</gtr:id><gtr:otherNames>Field AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0290FD7-8E99-4DDF-A6C9-44EBE4E29976"><gtr:id>E0290FD7-8E99-4DDF-A6C9-44EBE4E29976</gtr:id><gtr:title>Leishmania-specific surface antigens show sub-genus sequence variation and immune recognition.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09A9CA9E-B23C-4B76-A7D0-B7A26D7F9CC8"><gtr:id>09A9CA9E-B23C-4B76-A7D0-B7A26D7F9CC8</gtr:id><gtr:title>HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d9ff52e24b05f5b2cf2786523be6ff84"><gtr:id>d9ff52e24b05f5b2cf2786523be6ff84</gtr:id><gtr:otherNames>Zaitseva L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C46D0C17-0308-47B3-B1F5-0AF2DF86A0BF"><gtr:id>C46D0C17-0308-47B3-B1F5-0AF2DF86A0BF</gtr:id><gtr:title>Disease-associated XMRV sequences are consistent with laboratory contamination.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d0e4078101e2913852def3cc79eff29"><gtr:id>0d0e4078101e2913852def3cc79eff29</gtr:id><gtr:otherNames>Hu? S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BBC488E-D71A-4BB4-8ECE-CA31941085B8"><gtr:id>3BBC488E-D71A-4BB4-8ECE-CA31941085B8</gtr:id><gtr:title>Escape from R-peptide deletion in a ?-retrovirus.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd0712031dc167bd02265b80cf8e7e07"><gtr:id>fd0712031dc167bd02265b80cf8e7e07</gtr:id><gtr:otherNames>Schneider IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BFF4C86-FD26-4C5E-9039-6D8D3D066024"><gtr:id>3BFF4C86-FD26-4C5E-9039-6D8D3D066024</gtr:id><gtr:title>A quantitative proteomics design for systematic identification of protease cleavage events.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad1854c2a320f5fe8bd8170f93543b53"><gtr:id>ad1854c2a320f5fe8bd8170f93543b53</gtr:id><gtr:otherNames>Impens F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7BADA45E-3135-4B12-B4D5-632C18AF9935"><gtr:id>7BADA45E-3135-4B12-B4D5-632C18AF9935</gtr:id><gtr:title>Innate immunity against HIV: a priority target for HIV prevention research.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f6b6ae8702947976cd643c36a0d0bf5d"><gtr:id>f6b6ae8702947976cd643c36a0d0bf5d</gtr:id><gtr:otherNames>Borrow P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/081E1260-27AD-4131-B37D-C84E6738F84A"><gtr:id>081E1260-27AD-4131-B37D-C84E6738F84A</gtr:id><gtr:title>HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c660668f7b12ef3922555af6a0e45cc5"><gtr:id>c660668f7b12ef3922555af6a0e45cc5</gtr:id><gtr:otherNames>Bichel K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0A73EA1-9AB4-418B-B75B-30779BC020EE"><gtr:id>F0A73EA1-9AB4-418B-B75B-30779BC020EE</gtr:id><gtr:title>TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/67f6a49d89030d49da8ab007e4a081ae"><gtr:id>67f6a49d89030d49da8ab007e4a081ae</gtr:id><gtr:otherNames>Di Pietro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6251F988-9EA6-49C7-9CA2-9561BBA22F9E"><gtr:id>6251F988-9EA6-49C7-9CA2-9561BBA22F9E</gtr:id><gtr:title>Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides.</gtr:title><gtr:parentPublicationTitle>Chemical biology &amp; drug design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/257c231a152a044c321cbb42b71acaa1"><gtr:id>257c231a152a044c321cbb42b71acaa1</gtr:id><gtr:otherNames>Loh B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1747-0277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52EE3169-23EB-4821-8987-1B15EBF9AEE2"><gtr:id>52EE3169-23EB-4821-8987-1B15EBF9AEE2</gtr:id><gtr:title>The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/044f5e57988afec3522ce0a8b7ff48fe"><gtr:id>044f5e57988afec3522ce0a8b7ff48fe</gtr:id><gtr:otherNames>Pardieu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54D465B9-93D6-4CC6-B5C8-80A8D295E86E"><gtr:id>54D465B9-93D6-4CC6-B5C8-80A8D295E86E</gtr:id><gtr:title>Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/78ce7ce6c34651c317706ca694dff341"><gtr:id>78ce7ce6c34651c317706ca694dff341</gtr:id><gtr:otherNames>Kanhere A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0050E6A1-7B97-4EE9-811D-E62C5184535B"><gtr:id>0050E6A1-7B97-4EE9-811D-E62C5184535B</gtr:id><gtr:title>Error, reproducibility and sensitivity: a pipeline for data processing of Agilent oligonucleotide expression arrays.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d356f7cfe1e9a97102f4025fe5a3215"><gtr:id>3d356f7cfe1e9a97102f4025fe5a3215</gtr:id><gtr:otherNames>Chain B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E76B2FBC-DBB6-418E-BCAD-0DC278F605D1"><gtr:id>E76B2FBC-DBB6-418E-BCAD-0DC278F605D1</gtr:id><gtr:title>CPSF6 defines a conserved capsid interface that modulates HIV-1 replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2a6beffb1b3dfaecfccd9f955cc3b231"><gtr:id>2a6beffb1b3dfaecfccd9f955cc3b231</gtr:id><gtr:otherNames>Price AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D145E875-DE9B-44A6-BEAE-2721D8283F0E"><gtr:id>D145E875-DE9B-44A6-BEAE-2721D8283F0E</gtr:id><gtr:title>Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8F9A6CD-3503-4E69-B7E1-CBB00BC1B74F"><gtr:id>E8F9A6CD-3503-4E69-B7E1-CBB00BC1B74F</gtr:id><gtr:title>Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b999bff29ae3584c98fe490444298f8b"><gtr:id>b999bff29ae3584c98fe490444298f8b</gtr:id><gtr:otherNames>Perro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E4872FD-1992-4348-B086-7B8375FCDA5B"><gtr:id>3E4872FD-1992-4348-B086-7B8375FCDA5B</gtr:id><gtr:title>Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e8005ca9db27435e99e117da5712d43"><gtr:id>5e8005ca9db27435e99e117da5712d43</gtr:id><gtr:otherNames>Macdonald DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E7E5311C-A74F-49AE-B48A-3D481EB848AF"><gtr:id>E7E5311C-A74F-49AE-B48A-3D481EB848AF</gtr:id><gtr:title>Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/292b41fa56f474420b9e8bde21def9a9"><gtr:id>292b41fa56f474420b9e8bde21def9a9</gtr:id><gtr:otherNames>Mlcochova P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/582F38AE-FF32-4FAF-966D-9638A41985F2"><gtr:id>582F38AE-FF32-4FAF-966D-9638A41985F2</gtr:id><gtr:title>Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b5ae5ab08033b049c445101cf1d5a87"><gtr:id>9b5ae5ab08033b049c445101cf1d5a87</gtr:id><gtr:otherNames>Garson JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01A10635-3795-4C15-ACD1-E1FB51F16969"><gtr:id>01A10635-3795-4C15-ACD1-E1FB51F16969</gtr:id><gtr:title>Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44CCA805-2473-4EA5-85FC-A68A5C25524F"><gtr:id>44CCA805-2473-4EA5-85FC-A68A5C25524F</gtr:id><gtr:title>Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6ae03fe329f6f39f6142945d9f563e49"><gtr:id>6ae03fe329f6f39f6142945d9f563e49</gtr:id><gtr:otherNames>Xue SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36A121E3-0145-400A-BDA9-5C52E2D45B25"><gtr:id>36A121E3-0145-400A-BDA9-5C52E2D45B25</gtr:id><gtr:title>Upregulation of TRIM5a gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5a genotype has no impact on virus acquisition or vaccination outcome.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d601c726d34be556fecbbd27cb08186"><gtr:id>2d601c726d34be556fecbbd27cb08186</gtr:id><gtr:otherNames>Mattiuzzo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF2B2390-5230-4C7F-81C6-0360A90B7BAD"><gtr:id>AF2B2390-5230-4C7F-81C6-0360A90B7BAD</gtr:id><gtr:title>HIV-1 evades innate immune recognition through specific cofactor recruitment.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/34c1e8ababaaac31f24b1fb218be5bbb"><gtr:id>34c1e8ababaaac31f24b1fb218be5bbb</gtr:id><gtr:otherNames>Rasaiyaah J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B4A32D56-7422-4510-8284-46A4DE5B4CE5"><gtr:id>B4A32D56-7422-4510-8284-46A4DE5B4CE5</gtr:id><gtr:title>TriTrypDB: a functional genomic resource for the Trypanosomatidae.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdc3d43308c9cdef99af1a55f2556f74"><gtr:id>bdc3d43308c9cdef99af1a55f2556f74</gtr:id><gtr:otherNames>Aslett M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/50A589E7-861C-4571-ABA6-0FFCBF463FBC"><gtr:id>50A589E7-861C-4571-ABA6-0FFCBF463FBC</gtr:id><gtr:title>Diverse HIV viruses are targeted by a conformationally dynamic antiviral.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d6994fc2e6e840b1c3dc3b989e831439"><gtr:id>d6994fc2e6e840b1c3dc3b989e831439</gtr:id><gtr:otherNames>Caines ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BB44F1CF-F8B8-4F88-A0A3-EE905DBC5A88"><gtr:id>BB44F1CF-F8B8-4F88-A0A3-EE905DBC5A88</gtr:id><gtr:title>Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f89c7b4622f2153cac81da53204ade0e"><gtr:id>f89c7b4622f2153cac81da53204ade0e</gtr:id><gtr:otherNames>Chan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C1E99DB-D8DD-4133-A5B0-C6F501B46929"><gtr:id>4C1E99DB-D8DD-4133-A5B0-C6F501B46929</gtr:id><gtr:title>No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5cac4a32cea8345e9a184ca5f2dc240f"><gtr:id>5cac4a32cea8345e9a184ca5f2dc240f</gtr:id><gtr:otherNames>Sakuma T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7BF7064D-4817-452B-BD84-D1B216E7346F"><gtr:id>7BF7064D-4817-452B-BD84-D1B216E7346F</gtr:id><gtr:title>Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients.</gtr:title><gtr:parentPublicationTitle>Immunotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f26c68aa9ecea466134c7126ebe179aa"><gtr:id>f26c68aa9ecea466134c7126ebe179aa</gtr:id><gtr:otherNames>Hardwick N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1750-743X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/635655B2-EFC0-4AEB-A164-4BFA4B06E284"><gtr:id>635655B2-EFC0-4AEB-A164-4BFA4B06E284</gtr:id><gtr:title>HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfe8677cb938dc1232570dc209d4c71e"><gtr:id>cfe8677cb938dc1232570dc209d4c71e</gtr:id><gtr:otherNames>Tsang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/07191375-0117-4B38-AFD8-E48124DF95D4"><gtr:id>07191375-0117-4B38-AFD8-E48124DF95D4</gtr:id><gtr:title>A tail of Tetherin: how pandemic HIV-1 conquered the world.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1468a3c79a930345b1162a38bc32d1aa"><gtr:id>1468a3c79a930345b1162a38bc32d1aa</gtr:id><gtr:otherNames>Gupta RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71846A1A-B52F-4D2B-B384-74E1E9D85CF9"><gtr:id>71846A1A-B52F-4D2B-B384-74E1E9D85CF9</gtr:id><gtr:title>Hare TRIM5a restricts divergent retroviruses and exhibits significant sequence variation from closely related lagomorpha TRIM5 genes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4163edd090b7f7934101c6c7f3ffd2b9"><gtr:id>4163edd090b7f7934101c6c7f3ffd2b9</gtr:id><gtr:otherNames>Fletcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/78F70C47-8380-4B0F-82E2-2F316EBC823F"><gtr:id>78F70C47-8380-4B0F-82E2-2F316EBC823F</gtr:id><gtr:title>Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5127c337c4d35c97966a996e685b8462"><gtr:id>5127c337c4d35c97966a996e685b8462</gtr:id><gtr:otherNames>McEwan WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3BBC64D-689E-4FD4-8CC2-3B2468A87B35"><gtr:id>B3BBC64D-689E-4FD4-8CC2-3B2468A87B35</gtr:id><gtr:title>Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a22858f758e08c8666a044713dd48bb7"><gtr:id>a22858f758e08c8666a044713dd48bb7</gtr:id><gtr:otherNames>Huthoff H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C4C5925-0B1C-41FE-949D-C33C9AF0E3B3"><gtr:id>0C4C5925-0B1C-41FE-949D-C33C9AF0E3B3</gtr:id><gtr:title>Src-mediated regulation of inflammatory responses by actin polymerization.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0ef082f96e626cce81f78fe979e8c994"><gtr:id>0ef082f96e626cce81f78fe979e8c994</gtr:id><gtr:otherNames>Kim JY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF27E4BD-ECF4-40DA-9C1C-D33BFDEB260D"><gtr:id>DF27E4BD-ECF4-40DA-9C1C-D33BFDEB260D</gtr:id><gtr:title>Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/387e56f534a8a1ecfad6114c7f9cb2ae"><gtr:id>387e56f534a8a1ecfad6114c7f9cb2ae</gtr:id><gtr:otherNames>Knight S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39B1FEC7-E972-48F9-98F8-107FECC167E7"><gtr:id>39B1FEC7-E972-48F9-98F8-107FECC167E7</gtr:id><gtr:title>Heat shock protein 90 controls HIV-1 reactivation from latency.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/16a723b10317ba9aca23158c9a6c8606"><gtr:id>16a723b10317ba9aca23158c9a6c8606</gtr:id><gtr:otherNames>Anderson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA9D7FFC-906E-4117-836D-2684F3455EA0"><gtr:id>EA9D7FFC-906E-4117-836D-2684F3455EA0</gtr:id><gtr:title>Hypochlorous acid: a natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5d0b5306dd5fb8220a08bc0018485729"><gtr:id>5d0b5306dd5fb8220a08bc0018485729</gtr:id><gtr:otherNames>Prokopowicz ZM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B9B818D9-FA6F-4D0B-BA8A-56DD37E46F82"><gtr:id>B9B818D9-FA6F-4D0B-BA8A-56DD37E46F82</gtr:id><gtr:title>Innate immunity against HIV: a priority target for HIV prevention research.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f6b6ae8702947976cd643c36a0d0bf5d"><gtr:id>f6b6ae8702947976cd643c36a0d0bf5d</gtr:id><gtr:otherNames>Borrow P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01D9D3CC-A2F5-4C4B-93BF-2E82EA1EAD5F"><gtr:id>01D9D3CC-A2F5-4C4B-93BF-2E82EA1EAD5F</gtr:id><gtr:title>A model for cofactor use during HIV-1 reverse transcription and nuclear entry.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d849bcff7512ae0e8f595615237a927"><gtr:id>7d849bcff7512ae0e8f595615237a927</gtr:id><gtr:otherNames>Hilditch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B10A3AFA-B1E4-41C1-9E8F-F998D41F2845"><gtr:id>B10A3AFA-B1E4-41C1-9E8F-F998D41F2845</gtr:id><gtr:title>Endoplasmic reticulum degradation-enhancing a-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/439b5ba9e59cc5db5573c4d16339e4ab"><gtr:id>439b5ba9e59cc5db5573c4d16339e4ab</gtr:id><gtr:otherNames>Guiliano DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52D1517E-9A20-4980-A00B-DEE13FFB7AC9"><gtr:id>52D1517E-9A20-4980-A00B-DEE13FFB7AC9</gtr:id><gtr:title>Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/95729c2d3a47703ec5f65134a7553513"><gtr:id>95729c2d3a47703ec5f65134a7553513</gtr:id><gtr:otherNames>Tomlinson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/592A6AFD-1978-4CDD-973D-6EC47123FF7E"><gtr:id>592A6AFD-1978-4CDD-973D-6EC47123FF7E</gtr:id><gtr:title>Testing the theory of immune selection in cancers that break the rules of transplantation.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42FC02F9-FCF8-4BE9-A4F2-E233095866A7"><gtr:id>42FC02F9-FCF8-4BE9-A4F2-E233095866A7</gtr:id><gtr:title>PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/503b54c73715620166f20a676a65bbdb"><gtr:id>503b54c73715620166f20a676a65bbdb</gtr:id><gtr:otherNames>Karwacz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6CF26DB9-F0BC-4149-A903-4480D7F50D9B"><gtr:id>6CF26DB9-F0BC-4149-A903-4480D7F50D9B</gtr:id><gtr:title>Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5c2d35d76a3ff3436246776122a7aa9"><gtr:id>f5c2d35d76a3ff3436246776122a7aa9</gtr:id><gtr:otherNames>Kl?verpris HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B78A9FF-215B-430C-A5DA-89EDF9050927"><gtr:id>7B78A9FF-215B-430C-A5DA-89EDF9050927</gtr:id><gtr:title>DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathway.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5ada59437f6265f4c2952eb2c8878e9"><gtr:id>f5ada59437f6265f4c2952eb2c8878e9</gtr:id><gtr:otherNames>Le Bert N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/29ED220A-58EB-4E71-B415-0447CFB9FD73"><gtr:id>29ED220A-58EB-4E71-B415-0447CFB9FD73</gtr:id><gtr:title>Molecular immunology lessons from therapeutic T-cell receptor gene transfer.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c31326fe2d7119af01381f29a5e77427"><gtr:id>c31326fe2d7119af01381f29a5e77427</gtr:id><gtr:otherNames>Thomas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5E95D09-52B0-42C3-8084-AE6A52FF6791"><gtr:id>C5E95D09-52B0-42C3-8084-AE6A52FF6791</gtr:id><gtr:title>Human MHC Class I-restricted high avidity CD4(+) T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.</gtr:title><gtr:parentPublicationTitle>Oncoimmunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6ae03fe329f6f39f6142945d9f563e49"><gtr:id>6ae03fe329f6f39f6142945d9f563e49</gtr:id><gtr:otherNames>Xue SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2162-4011</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B6E404B5-B37C-4637-BB1E-418E54642D93"><gtr:id>B6E404B5-B37C-4637-BB1E-418E54642D93</gtr:id><gtr:title>Active site remodeling switches HIV specificity of antiretroviral TRIMCyp.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2a6beffb1b3dfaecfccd9f955cc3b231"><gtr:id>2a6beffb1b3dfaecfccd9f955cc3b231</gtr:id><gtr:otherNames>Price AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20C98D37-C24A-47A4-9B62-D05E9D9FC93D"><gtr:id>20C98D37-C24A-47A4-9B62-D05E9D9FC93D</gtr:id><gtr:title>Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae44d82633c36fa9eba6e8c8a9005700"><gtr:id>ae44d82633c36fa9eba6e8c8a9005700</gtr:id><gtr:otherNames>Wood A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/91DE9D65-38D4-44D1-AB12-BC515F513E99"><gtr:id>91DE9D65-38D4-44D1-AB12-BC515F513E99</gtr:id><gtr:title>Lentiviral vectors targeted to MHC II are effective in immunization.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0fe67292440a9860f2973e2f2b6ede31"><gtr:id>0fe67292440a9860f2973e2f2b6ede31</gtr:id><gtr:otherNames>Ageichik A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6898EE95-A4D7-44C8-9020-31260F3CC70E"><gtr:id>6898EE95-A4D7-44C8-9020-31260F3CC70E</gtr:id><gtr:title>Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: landmark HIV-1 research honoured.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1806d57777bec30b4d217f5aa67467e"><gtr:id>c1806d57777bec30b4d217f5aa67467e</gtr:id><gtr:otherNames>Berkhout B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D477DF3-77F1-4078-A6C2-0454A676AB0A"><gtr:id>7D477DF3-77F1-4078-A6C2-0454A676AB0A</gtr:id><gtr:title>Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/85CC4E69-F845-465A-9ECC-7E9DF017D56C"><gtr:id>85CC4E69-F845-465A-9ECC-7E9DF017D56C</gtr:id><gtr:title>Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8e06e317fad1d8db4dee8b7c2ff53fba"><gtr:id>8e06e317fad1d8db4dee8b7c2ff53fba</gtr:id><gtr:otherNames>Arce F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2424DCC-801B-4B41-9706-CA66A9CE89C9"><gtr:id>E2424DCC-801B-4B41-9706-CA66A9CE89C9</gtr:id><gtr:title>Structural basis for nuclear import of splicing factors by human Transportin 3.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/67c749d627f6a6bccbe386923cc5a048"><gtr:id>67c749d627f6a6bccbe386923cc5a048</gtr:id><gtr:otherNames>Maertens GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/419A0A9F-8AD0-426D-B89C-633E6D22D678"><gtr:id>419A0A9F-8AD0-426D-B89C-633E6D22D678</gtr:id><gtr:title>RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/60BEA943-03F5-487B-AD06-8407EE0531C1"><gtr:id>60BEA943-03F5-487B-AD06-8407EE0531C1</gtr:id><gtr:title>Methods of preparation and analysis of intracellular reverse transcription complexes.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/979C6764-AADB-47FF-86CF-3F5577F0317A"><gtr:id>979C6764-AADB-47FF-86CF-3F5577F0317A</gtr:id><gtr:title>DNA fusion vaccine designs to induce tumor-lytic CD8+ T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/442b429f6b5f836091635bace93c3863"><gtr:id>442b429f6b5f836091635bace93c3863</gtr:id><gtr:otherNames>Campos-Perez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4FBD6BAB-684A-4FD8-9A6A-6C6FEC371504"><gtr:id>4FBD6BAB-684A-4FD8-9A6A-6C6FEC371504</gtr:id><gtr:title>p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8? T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eeadefcfa805429fe4021215f24d5f0f"><gtr:id>eeadefcfa805429fe4021215f24d5f0f</gtr:id><gtr:otherNames>Henson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/202896FC-588E-48F4-8252-90D92C789637"><gtr:id>202896FC-588E-48F4-8252-90D92C789637</gtr:id><gtr:title>The HTR1A and HTR1B receptor genes influence stress-related information processing.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/90b622be61f8011765e78c73253ee9a3"><gtr:id>90b622be61f8011765e78c73253ee9a3</gtr:id><gtr:otherNames>Mekli K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB9665E8-ACF5-4858-8F76-3D2E8A81B7F8"><gtr:id>CB9665E8-ACF5-4858-8F76-3D2E8A81B7F8</gtr:id><gtr:title>Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b6edbf63ed60ec50dcf00c4121c43bfc"><gtr:id>b6edbf63ed60ec50dcf00c4121c43bfc</gtr:id><gtr:otherNames>Uttenthal B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41602D46-B5FE-4868-BCB3-E7227436F0D7"><gtr:id>41602D46-B5FE-4868-BCB3-E7227436F0D7</gtr:id><gtr:title>4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e8005ca9db27435e99e117da5712d43"><gtr:id>5e8005ca9db27435e99e117da5712d43</gtr:id><gtr:otherNames>Macdonald DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46C17A95-37E0-45CD-8703-9645A744E086"><gtr:id>46C17A95-37E0-45CD-8703-9645A744E086</gtr:id><gtr:title>Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2046d415c257b2fe0d1ecb7aa072c4d1"><gtr:id>2046d415c257b2fe0d1ecb7aa072c4d1</gtr:id><gtr:otherNames>Parry CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3425BD8F-B322-47CC-80A7-F590638DAE4A"><gtr:id>3425BD8F-B322-47CC-80A7-F590638DAE4A</gtr:id><gtr:title>Upregulation of TRIM5a gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5a genotype has no impact on virus acquisition or vaccination outcome.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d601c726d34be556fecbbd27cb08186"><gtr:id>2d601c726d34be556fecbbd27cb08186</gtr:id><gtr:otherNames>Mattiuzzo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/29C49083-16F2-4C15-87DF-025DECCB18D6"><gtr:id>29C49083-16F2-4C15-87DF-025DECCB18D6</gtr:id><gtr:title>Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47E21743-F1D7-4EA5-9FAA-3EC0DEF3D362"><gtr:id>47E21743-F1D7-4EA5-9FAA-3EC0DEF3D362</gtr:id><gtr:title>Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/240a27c7bd5d10365eaae398f59768ee"><gtr:id>240a27c7bd5d10365eaae398f59768ee</gtr:id><gtr:otherNames>Zhou L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C287B18-5F55-4544-8E10-1DA0CC51F0A7"><gtr:id>4C287B18-5F55-4544-8E10-1DA0CC51F0A7</gtr:id><gtr:title>HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5c2d35d76a3ff3436246776122a7aa9"><gtr:id>f5c2d35d76a3ff3436246776122a7aa9</gtr:id><gtr:otherNames>Kl?verpris HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DDE536B0-B175-4957-BA9A-BD706B36E1A2"><gtr:id>DDE536B0-B175-4957-BA9A-BD706B36E1A2</gtr:id><gtr:title>Inhibition of retroviral replication by members of the TRIM protein family.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4163edd090b7f7934101c6c7f3ffd2b9"><gtr:id>4163edd090b7f7934101c6c7f3ffd2b9</gtr:id><gtr:otherNames>Fletcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/154FEEA0-DA70-4DB3-A7E7-243AE43A06C2"><gtr:id>154FEEA0-DA70-4DB3-A7E7-243AE43A06C2</gtr:id><gtr:title>Targeted delivery of antigen processing inhibitors to antigen presenting cells via mannose receptors.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e197a00ba92702c3846ba48558e422c4"><gtr:id>e197a00ba92702c3846ba48558e422c4</gtr:id><gtr:otherNames>Raiber EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/802ACF5F-F919-4847-A87B-D5C535FF0266"><gtr:id>802ACF5F-F919-4847-A87B-D5C535FF0266</gtr:id><gtr:title>Mode of virus rescue determines the acquisition of VHS mutations in VP22-negative herpes simplex virus 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0a487439957a8a457771f1264aa85442"><gtr:id>0a487439957a8a457771f1264aa85442</gtr:id><gtr:otherNames>Ebert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F36AA861-642A-4177-9DF5-CB222F79BE3D"><gtr:id>F36AA861-642A-4177-9DF5-CB222F79BE3D</gtr:id><gtr:title>IL-2 regulates expression of C-MAF in human CD4 T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d4bd41f5e795706d066b9db464defb69"><gtr:id>d4bd41f5e795706d066b9db464defb69</gtr:id><gtr:otherNames>Rani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BE33AAA9-4EB5-422F-A78B-AE7EC8C8EA54"><gtr:id>BE33AAA9-4EB5-422F-A78B-AE7EC8C8EA54</gtr:id><gtr:title>Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd2ca761a141ca7db238491b9127a7d8"><gtr:id>bd2ca761a141ca7db238491b9127a7d8</gtr:id><gtr:otherNames>Qasim W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05B4446C-0400-4A89-94B5-AD1171E48BE3"><gtr:id>05B4446C-0400-4A89-94B5-AD1171E48BE3</gtr:id><gtr:title>Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f25e8a22839c8eaf9492900e3ab52a36"><gtr:id>f25e8a22839c8eaf9492900e3ab52a36</gtr:id><gtr:otherNames>Dietrich I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8EF706A1-0118-40EB-9841-AC672B03EEFB"><gtr:id>8EF706A1-0118-40EB-9841-AC672B03EEFB</gtr:id><gtr:title>Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9fe58dc6a098327a26c6ec7f9af7dc38"><gtr:id>9fe58dc6a098327a26c6ec7f9af7dc38</gtr:id><gtr:otherNames>Murchison EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22FEB9C6-7CE5-4010-A1D4-97A70354845F"><gtr:id>22FEB9C6-7CE5-4010-A1D4-97A70354845F</gtr:id><gtr:title>Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c18528a81eb674069f4bfa80db10e10c"><gtr:id>c18528a81eb674069f4bfa80db10e10c</gtr:id><gtr:otherNames>Kundu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9BF46FEA-5E15-414D-90A6-2A5C279D5C8B"><gtr:id>9BF46FEA-5E15-414D-90A6-2A5C279D5C8B</gtr:id><gtr:title>Differential requirement for cathepsin D for processing of the full length and C-terminal fragment of the malaria antigen MSP1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9a72f69a17c5546c6057221e2636df10"><gtr:id>9a72f69a17c5546c6057221e2636df10</gtr:id><gtr:otherNames>Tulone C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CDF0D693-D576-4ECA-A825-4B232AD49AC0"><gtr:id>CDF0D693-D576-4ECA-A825-4B232AD49AC0</gtr:id><gtr:title>Diversity of TRIM5a and TRIMCyp sequences in cynomolgus macaques from different geographical origins.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f6ba1b9e95629587f1143575d6b64393"><gtr:id>f6ba1b9e95629587f1143575d6b64393</gtr:id><gtr:otherNames>Berry NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/35B507E5-B0AB-4CB2-913D-16A149A149CC"><gtr:id>35B507E5-B0AB-4CB2-913D-16A149A149CC</gtr:id><gtr:title>Genome Sequence of Human Herpesvirus 7 Strain UCL-1.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/445e89510add42a0b7afe91dfd55d3ee"><gtr:id>445e89510add42a0b7afe91dfd55d3ee</gtr:id><gtr:otherNames>Donaldson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4741E94D-9F30-42EC-B0D9-632EDA4A16FC"><gtr:id>4741E94D-9F30-42EC-B0D9-632EDA4A16FC</gtr:id><gtr:title>No evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohort.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0788e79a32e1e1b065a44e20d7ea9c5"><gtr:id>f0788e79a32e1e1b065a44e20d7ea9c5</gtr:id><gtr:otherNames>Gray ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/689E97DB-8AA1-41FC-9A8A-40C10020D861"><gtr:id>689E97DB-8AA1-41FC-9A8A-40C10020D861</gtr:id><gtr:title>Obituary: Kuan-Teh Jeang.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1806d57777bec30b4d217f5aa67467e"><gtr:id>c1806d57777bec30b4d217f5aa67467e</gtr:id><gtr:otherNames>Berkhout B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/12DC82CE-F9F9-46A5-9AB0-9864A8694D0D"><gtr:id>12DC82CE-F9F9-46A5-9AB0-9864A8694D0D</gtr:id><gtr:title>Interactions between HIV-1 and the cell-autonomous innate immune system.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c9d8dc102629560a2c32a6e4c03990a0"><gtr:id>c9d8dc102629560a2c32a6e4c03990a0</gtr:id><gtr:otherNames>Towers GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9470541E-9537-4827-B39E-EBFBAF354FE9"><gtr:id>9470541E-9537-4827-B39E-EBFBAF354FE9</gtr:id><gtr:title>Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9a115fb22ae8b5eb1d761afe50087d24"><gtr:id>9a115fb22ae8b5eb1d761afe50087d24</gtr:id><gtr:otherNames>McCormick AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/59C9C601-9048-4959-ADFB-B6E379B6A491"><gtr:id>59C9C601-9048-4959-ADFB-B6E379B6A491</gtr:id><gtr:title>Phylogenetic analysis of murine leukemia virus sequences from longitudinally sampled chronic fatigue syndrome patients suggests PCR contamination rather than viral evolution.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1726215f97cf2a56089d86c8d135545"><gtr:id>d1726215f97cf2a56089d86c8d135545</gtr:id><gtr:otherNames>Katzourakis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31B386BB-4D28-4F8F-B578-F67798A4777D"><gtr:id>31B386BB-4D28-4F8F-B578-F67798A4777D</gtr:id><gtr:title>Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf29f7227bad6014781959a7fbeeeb53"><gtr:id>bf29f7227bad6014781959a7fbeeeb53</gtr:id><gtr:otherNames>Vozzolo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/99E038C8-C7B5-4009-B284-AFEF72DF071F"><gtr:id>99E038C8-C7B5-4009-B284-AFEF72DF071F</gtr:id><gtr:title>Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5535e5b095530624beba13046aa94cd9"><gtr:id>5535e5b095530624beba13046aa94cd9</gtr:id><gtr:otherNames>Ylinen LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9721629</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>80</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>